Methadone Access: Public Transit vs. Driving Times in Connecticut
Publication Title: Travel Time to Methadone Treatment Via Personal Vehicle vs Public Transit
Summary
- Question
This study compared travel times to methadone treatment programs for opioid use disorder in Connecticut, focusing on differences between personal vehicle travel and public transit. Researchers sought to identify differences based on geographic and demographic factors.
- Why it Matters
- Methadone is a critical medication for treating opioid use disorder, reducing overdose deaths and improving treatment outcomes. However, accessing methadone often requires daily visits to specialized clinics, posing a significant challenge for individuals without personal vehicles. This research highlights transportation-related barriers to treatment, particularly for communities with limited public transit options. Addressing these barriers could improve access to life-saving treatment and reduce opioid-related deaths.
- Methods
- The researchers conducted a geospatial analysis of travel times to 29 methadone treatment facilities in Connecticut. Using data from 2,702 census block groups (CBGs), they calculated median travel times by personal vehicle and public transit. They also examined demographic characteristics, car ownership rates, and opioid overdose death rates within these CBGs.
- Key Findings
Median travel time to the nearest methadone clinic was 11 minutes by personal vehicle but 41.7 minutes by public transit. Over half (53%) of CBGs lacked adequate public transit access, with rural and suburban areas facing the longest travel times. CBGs with higher percentages of white residents or located in rural areas experienced longer travel times compared to urban and more diverse communities. Among CBGs with the highest opioid overdose death rates, 34% had poor public transit access.
- Implications
The findings reveal transportation barriers to methadone treatment, especially for those relying on public transit. These barriers particularly affect rural and suburban communities, as well as areas with low car ownership. Policymakers could address these issues by expanding access to mobile methadone units, increasing take-home methadone doses, or improving public transit connectivity to treatment centers. Reducing these barriers could enhance treatment uptake and retention, ultimately saving lives.
- Next Steps
- The researchers suggest targeting areas with high overdose death rates, low car ownership, and poor public transit access for interventions. They recommend exploring mobile methadone services, telehealth options, and regulatory changes to reduce daily in-person visit requirements for methadone treatment.
- Funding Information
- This research was supported by the National Institutes of Health (awards R61DA057675, R01DA060716, and R37DA015612) and the Centers for Disease Control and Prevention (award NH28CE003554 and NU38PS004651). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Full Citation
Authors
Benjamin Howell, MD, MPH, MHS
First AuthorAssistant Professor of Medicine (General Medicine)
Gregg Gonsalves, PhD
Last AuthorProfessor of Epidemiology (Microbial Diseases)